A randomized phase IIb study comparing levetiracetam alone with lacosamide add-on for reduction of epileptic seizure after brain tumor surgery
Phase 2
Recruiting
- Conditions
- Brain tumors
- Registration Number
- JPRN-UMIN000031896
- Lead Sponsor
- Department of Neurosurgery, University of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 235
Inclusion Criteria
Not provided
Exclusion Criteria
1) a patient who has a past-history of severe adverse effect due to LEV, PHT, fPHT or LCM 2) a patient who is treated with intra-venous LEV, fPHT or LCM 3) a patient who is treated with oral PHT or LCM
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method